Novo Nordisk shares jump 8% after Wegovy sales beat expectations

• 

  Novo Nordisk's Wegovy Sales Beat Expectations

  Business - The Wall Street Journal - November 6

• Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

  Business - CNBC - October 30

• The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

  Top stories - CBS News - November 4
• 

  Novo Nordisk Launches Wegovy Weight-Loss Drug in China

  Business - The Wall Street Journal - 2 days ago

• Barclays shares hit nine-year high after third quarter profit jumps 23%, beating expectations

  Business - CNBC - October 24

• Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

  Business - CNBC - October 23

• Amazon shares jump 6% after earnings beat

  Business - CNBC - November 1

• Snap shares jump after results come in better than expected

  Business - MarketWatch - October 30

More from CNBC

• Target's recent trade imports data tells the real story behind massive earnings miss

  Business - CNBC - 9 minutes ago

• Bitcoin hits fresh record, races toward $100,000 as rally continues

  Business - CNBC - 16 minutes ago

• Trump and Fed Chair Powell could be set on a collision course over interest rates

  Business - CNBC - 1 hour ago

• Nvidia says it will sell more of its next-generation Blackwell chips than previously anticipated

  Business - CNBC - 13 hours ago

• CFPB expands oversight of digital payments services including Apple Pay, Cash App and PayPal

  Business - CNBC - 39 minutes ago